Headcount increased by 28 to approximately 160, with expectation of “positive synergies” and expanded addressable markets, ...
Medical Segment Milestone -- Announced FDA 510 (k) submission for ThermAffyx, with expected revenue generation later in 2026 ...
This important study uses a tripartite transdiagnostic computational framework to distinguish depression-specific, anxiety-specific, and shared psychopathology dimensions, in their relationships to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results